NEW MARKERS. “D-Ser and D-Ala bind to the glycine site of NMDA receptors in the central nervous system. Both D-Ser and D-Ala are noted as novel candidate biomarkers of neuronal diseases, and novel therapies focusing on these two D-amino acids are also expected.”
https://lnkd.in/e7enTMS
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022